Global IVF Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12249298

Publication Date:

December 13, 2024

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global IVF market size was valued at US$ million in 2023. With growing demand in downstream market, the IVF is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global IVF market. IVF are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of IVF. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the IVF market.
In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm outside the body, in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2鈥�6 days, and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for IVF in US$ by following Product Segments.: Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) and Pre-implantation Genetic Diagnosis (PGD)
Company profiles are primarily based on public domain information including company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience
Key Features:
The report on IVF market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the IVF market. It may include historical data, market segmentation by Type (e.g., Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the IVF market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the IVF market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the IVF industry. This include advancements in IVF technology, IVF new entrants, IVF new investment, and other innovations that are shaping the future of IVF.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the IVF market. It includes factors influencing customer ' purchasing decisions, preferences for IVF product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the IVF market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting IVF market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the IVF market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the IVF industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the IVF market.
Market Segmentation:
IVF market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Intracytoplasmic Sperm Injection (ICSI)
Frozen Embryo Replacement (FER)
Pre-implantation Genetic Diagnosis (PGD)
Segmentation by application
Clone
Transgenic
Embryonic Stem Cell Isolation and Culture
Test Tube Baby
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global IVF Market Size 2019-2030
2.1.2 IVF Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 IVF Segment by Type
2.2.1 Intracytoplasmic Sperm Injection (ICSI)
2.2.2 Frozen Embryo Replacement (FER)
2.2.3 Pre-implantation Genetic Diagnosis (PGD)
2.3 IVF Market Size by Type
2.3.1 IVF Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global IVF Market Size Market Share by Type (2019-2024)
2.4 IVF Segment by Application
2.4.1 Clone
2.4.2 Transgenic
2.4.3 Embryonic Stem Cell Isolation and Culture
2.4.4 Test Tube Baby
2.5 IVF Market Size by Application
2.5.1 IVF Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global IVF Market Size Market Share by Application (2019-2024)
3 IVF Market Size by Player
3.1 IVF Market Size Market Share by Players
3.1.1 Global IVF Revenue by Players (2019-2024)
3.1.2 Global IVF Revenue Market Share by Players (2019-2024)
3.2 Global IVF Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IVF by Regions
4.1 IVF Market Size by Regions (2019-2024)
4.2 Americas IVF Market Size Growth (2019-2024)
4.3 APAC IVF Market Size Growth (2019-2024)
4.4 Europe IVF Market Size Growth (2019-2024)
4.5 Middle East & Africa IVF Market Size Growth (2019-2024)
5 Americas
5.1 Americas IVF Market Size by Country (2019-2024)
5.2 Americas IVF Market Size by Type (2019-2024)
5.3 Americas IVF Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVF Market Size by Region (2019-2024)
6.2 APAC IVF Market Size by Type (2019-2024)
6.3 APAC IVF Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe IVF by Country (2019-2024)
7.2 Europe IVF Market Size by Type (2019-2024)
7.3 Europe IVF Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa IVF by Region (2019-2024)
8.2 Middle East & Africa IVF Market Size by Type (2019-2024)
8.3 Middle East & Africa IVF Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global IVF Market Forecast
10.1 Global IVF Forecast by Regions (2025-2030)
10.1.1 Global IVF Forecast by Regions (2025-2030)
10.1.2 Americas IVF Forecast
10.1.3 APAC IVF Forecast
10.1.4 Europe IVF Forecast
10.1.5 Middle East & Africa IVF Forecast
10.2 Americas IVF Forecast by Country (2025-2030)
10.2.1 United States IVF Market Forecast
10.2.2 Canada IVF Market Forecast
10.2.3 Mexico IVF Market Forecast
10.2.4 Brazil IVF Market Forecast
10.3 APAC IVF Forecast by Region (2025-2030)
10.3.1 China IVF Market Forecast
10.3.2 Japan IVF Market Forecast
10.3.3 Korea IVF Market Forecast
10.3.4 Southeast Asia IVF Market Forecast
10.3.5 India IVF Market Forecast
10.3.6 Australia IVF Market Forecast
10.4 Europe IVF Forecast by Country (2025-2030)
10.4.1 Germany IVF Market Forecast
10.4.2 France IVF Market Forecast
10.4.3 UK IVF Market Forecast
10.4.4 Italy IVF Market Forecast
10.4.5 Russia IVF Market Forecast
10.5 Middle East & Africa IVF Forecast by Region (2025-2030)
10.5.1 Egypt IVF Market Forecast
10.5.2 South Africa IVF Market Forecast
10.5.3 Israel IVF Market Forecast
10.5.4 Turkey IVF Market Forecast
10.5.5 GCC Countries IVF Market Forecast
10.6 Global IVF Forecast by Type (2025-2030)
10.7 Global IVF Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Vitrolife AB
11.1.1 Vitrolife AB Company Information
11.1.2 Vitrolife AB IVF Product Offered
11.1.3 Vitrolife AB IVF Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Vitrolife AB Main Business Overview
11.1.5 Vitrolife AB Latest Developments
11.2 EMD Serono Inc
11.2.1 EMD Serono Inc Company Information
11.2.2 EMD Serono Inc IVF Product Offered
11.2.3 EMD Serono Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 EMD Serono Inc Main Business Overview
11.2.5 EMD Serono Inc Latest Developments
11.3 Irvine scientific
11.3.1 Irvine scientific Company Information
11.3.2 Irvine scientific IVF Product Offered
11.3.3 Irvine scientific IVF Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Irvine scientific Main Business Overview
11.3.5 Irvine scientific Latest Developments
11.4 Cooper Surgical Inc
11.4.1 Cooper Surgical Inc Company Information
11.4.2 Cooper Surgical Inc IVF Product Offered
11.4.3 Cooper Surgical Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Cooper Surgical Inc Main Business Overview
11.4.5 Cooper Surgical Inc Latest Developments
11.5 Cook Medical Inc
11.5.1 Cook Medical Inc Company Information
11.5.2 Cook Medical Inc IVF Product Offered
11.5.3 Cook Medical Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cook Medical Inc Main Business Overview
11.5.5 Cook Medical Inc Latest Developments
11.6 Thermo Fisher Scientific Inc
11.6.1 Thermo Fisher Scientific Inc Company Information
11.6.2 Thermo Fisher Scientific Inc IVF Product Offered
11.6.3 Thermo Fisher Scientific Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Thermo Fisher Scientific Inc Main Business Overview
11.6.5 Thermo Fisher Scientific Inc Latest Developments
11.7 Genea Biomedx
11.7.1 Genea Biomedx Company Information
11.7.2 Genea Biomedx IVF Product Offered
11.7.3 Genea Biomedx IVF Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Genea Biomedx Main Business Overview
11.7.5 Genea Biomedx Latest Developments
11.8 Auxogyn, Inc
11.8.1 Auxogyn, Inc Company Information
11.8.2 Auxogyn, Inc IVF Product Offered
11.8.3 Auxogyn, Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Auxogyn, Inc Main Business Overview
11.8.5 Auxogyn, Inc Latest Developments
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Information
11.9.2 Oxford Gene Technology IVF Product Offered
11.9.3 Oxford Gene Technology IVF Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Oxford Gene Technology Main Business Overview
11.9.5 Oxford Gene Technology Latest Developments
11.10 Ovascience
11.10.1 Ovascience Company Information
11.10.2 Ovascience IVF Product Offered
11.10.3 Ovascience IVF Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ovascience Main Business Overview
11.10.5 Ovascience Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂